Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

President Trump’s Secretary of Defense Pete Hegseth announced on social media: “Pentagon access is a privilege, not a right, So, here is @DeptofWar press credentialing FOR DUMMIES: Press no longer ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 6.54% at $68.29. The stock trailed the S&P 500, which registered a daily gain of 1.56%. On the other hand, the Dow registered a gain ...

In today's hyper-connected world, cyber threats are more sophisticated and frequent than ever - ransomware attacks, data breaches, social engineering scams, and advanced persistent threats targeting ...

Lozano is a rare disease mom, neuroscience Ph.D. candidate at UC Davis, and board member for the PURA Syndrome Foundation. In May, a historic moment in science and medicine was captured in a single ...

Please provide your email address to receive an email when new articles are posted on . A CRISPR-Cas9-based therapy reduced transthyretin levels in patients with hereditary amyloidosis and ...

How much social and public-health damage will Americans suffer before doing a U-turn on marijuana promotion? A new study finds that more than 40% of drivers who died in car accidents in one U.S.